Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (2315)	8/17/2010 1:05:35 PM
From: richardred	Respond to of 7242

UPDATE 1-Medtronic to buy Osteotech for about $120 mln Aug 17 (Reuters) - Medtronic Inc (MDT.N) agreed to buy orthopedic products maker Osteotech (OSTE.O) for about $120 million to add regenerative medicine to its biologics portfolio. The $6.50 per share cash offer from the medical device maker, represents a premium of 65 percent over Osteotech's Monday close of $3.94 on Nasdaq. Medtronic's offer comes amidst a tussle between Osteotech and a group of its shareholders that had most recently nominated four people to the company's board. Osteotech, which had been evaluating strategic alternatives, said its current board had unanimously approved the deal. Shares of the Eatontown, New Jersey-based Osteotech, which focuses on regenerative medicine, were up 64 percent at $6.49 Tuesday morning. (Reporting by Vidya L Nathan in Bangalore; Editing by Aradhana Aravindan) reuters.com

To: richardred who wrote (2315)	9/11/2010 3:24:54 PM
From: richardred	Respond to of 7242

Welsh Carson Taps Into Spinal Market with K2M Buy By Tom Salemi, Start-Up 9/1/2010 Executive Summary Start-Up -- Welsh, Carson, Anderson & Stowe, a long time investor in health care services companies, signaled its intent to invest more deeply in the device sector with the acquisition of a majority position in spinal company K2M Inc. sis.windhover.com welshcarson.com

To: richardred who wrote (2315)	10/18/2010 9:36:17 AM
From: richardred	Read Replies (2) \| Respond to of 7242

Another medical device maker bites the dust. St Jude to buy AGA Medical for over $1 bln Mon Oct 18, 2010 7:28am EDT * At $20.80, deal is 41 pct premium * AGA Medical went public in October NEW YORK Oct 18 (Reuters) - St Jude Medical Inc (STJ.N) will buy AGA Medical Holdings Inc (AGAM.O), a maker of devices to treat heart defects and vascular problems, for more than $1 billion in cash and stock, the companies said on Monday. At $20.80 per share, the deal values AGA Medical shares at a 41 percent premium to Friday's closing price. The companies valued the deal at about $1.3 billion, including the assumption of about $225 million in debt. AGA Medical went public in October at $14.50 per share. Its major shareholders include those affiliated with private equity firm Welsh, Carson, Anderson & Stowe, and AGA Medical's co-founder Franck Gougeon. The deal involves an even split between cash and stock. The exchange ratio for the stock component will be determined by the average closing price of St. Jude stock over 10 trading days, ending two days before the close of the exchange offer. St Jude said it expects the transaction to close by year's end and it does not affect its earnings outlook for 2010. (Reporting by Lewis Krauskopf, editing by Maureen Bavdek) reuters.com